Perennial Advisors, LLC Abb Vie Inc. Transaction History

Perennial Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $57,030 - $64,738	-536 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $526 - $586	5 Added 0.94%	536 $60,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $42,045 - $46,286	411 Added 342.5%	531 $57,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $6,439 - $8,693	-80 Reduced 40.0%	120 $13,000
Q1 2020 May 19, 2020	BUY	$64.5 - $97.79 $12,900 - $19,558	200 New	200 $13,000
Q1 2019 Apr 30, 2019	SELL	$77.14 - $90.79 $12,188 - $14,344	-158 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $8,891 - $9,884	-100 Reduced 38.76%	158 $15,000
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $3,864 - $5,174	-42 Reduced 14.0%	258 $24,000
Q4 2017 Jan 29, 2018	BUY	$89.56 - $98.21 $17,912 - $19,642	200 Added 200.0%	300 $29,000
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $6,984 - $8,922	100	100 $9,000

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Perennial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Perennial Advisors, LLC with notifications on news.